Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Loneliness | 6 | 2011 | 25 | 0.970 |
Why?
|
Health Surveys | 8 | 2015 | 239 | 0.820 |
Why?
|
Health Status | 6 | 2015 | 370 | 0.730 |
Why?
|
Quinidine | 5 | 2012 | 11 | 0.620 |
Why?
|
Dextromethorphan | 5 | 2012 | 11 | 0.610 |
Why?
|
Sleep | 4 | 2015 | 447 | 0.580 |
Why?
|
Mortality | 3 | 2005 | 150 | 0.490 |
Why?
|
Diabetic Neuropathies | 2 | 2012 | 41 | 0.380 |
Why?
|
Depressive Disorder | 3 | 2010 | 223 | 0.370 |
Why?
|
Middle Aged | 54 | 2018 | 25710 | 0.360 |
Why?
|
Social Isolation | 1 | 2010 | 67 | 0.350 |
Why?
|
Analgesics, Opioid | 3 | 2006 | 436 | 0.350 |
Why?
|
Male | 72 | 2018 | 42021 | 0.350 |
Why?
|
Depression | 5 | 2011 | 499 | 0.350 |
Why?
|
Physician-Patient Relations | 2 | 2005 | 622 | 0.340 |
Why?
|
Exercise Test | 4 | 2010 | 165 | 0.340 |
Why?
|
Aged | 44 | 2018 | 18939 | 0.330 |
Why?
|
Exercise Tolerance | 3 | 2005 | 52 | 0.330 |
Why?
|
Interpersonal Relations | 1 | 2010 | 174 | 0.330 |
Why?
|
Female | 63 | 2018 | 45769 | 0.320 |
Why?
|
Pseudobulbar Palsy | 2 | 2004 | 2 | 0.310 |
Why?
|
Humans | 102 | 2018 | 88635 | 0.310 |
Why?
|
Adult | 49 | 2018 | 26357 | 0.290 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 4 | 2001 | 94 | 0.290 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2010 | 187 | 0.290 |
Why?
|
Multiple Sclerosis | 3 | 2010 | 269 | 0.280 |
Why?
|
Actigraphy | 3 | 2015 | 58 | 0.280 |
Why?
|
Logistic Models | 6 | 2015 | 1205 | 0.280 |
Why?
|
Time Factors | 15 | 2018 | 5320 | 0.270 |
Why?
|
Health Services Accessibility | 2 | 2018 | 419 | 0.270 |
Why?
|
Laughter | 2 | 2006 | 4 | 0.270 |
Why?
|
Crying | 2 | 2006 | 6 | 0.270 |
Why?
|
Risk Factors | 16 | 2015 | 5452 | 0.270 |
Why?
|
Cross-Sectional Studies | 7 | 2015 | 1694 | 0.270 |
Why?
|
Neuropsychological Tests | 2 | 2004 | 507 | 0.260 |
Why?
|
Longitudinal Studies | 7 | 2015 | 1051 | 0.260 |
Why?
|
Physical Fitness | 1 | 2005 | 51 | 0.250 |
Why?
|
Physician Incentive Plans | 1 | 2005 | 20 | 0.250 |
Why?
|
Azathioprine | 1 | 2005 | 125 | 0.250 |
Why?
|
United States | 15 | 2015 | 6888 | 0.240 |
Why?
|
Disclosure | 1 | 2005 | 109 | 0.240 |
Why?
|
Trust | 1 | 2005 | 97 | 0.240 |
Why?
|
Cesarean Section | 2 | 1997 | 140 | 0.230 |
Why?
|
Social Support | 4 | 2010 | 204 | 0.230 |
Why?
|
Anesthesia, Obstetrical | 2 | 1994 | 28 | 0.230 |
Why?
|
Aging | 4 | 2014 | 712 | 0.220 |
Why?
|
Anesthesia, Epidural | 2 | 1994 | 32 | 0.220 |
Why?
|
Patient Participation | 1 | 2005 | 224 | 0.220 |
Why?
|
Morphine | 3 | 2002 | 130 | 0.220 |
Why?
|
Immunosuppressive Agents | 2 | 2005 | 993 | 0.220 |
Why?
|
Aged, 80 and over | 20 | 2018 | 6726 | 0.210 |
Why?
|
Morbidity | 1 | 2003 | 149 | 0.210 |
Why?
|
Social Class | 1 | 2003 | 134 | 0.210 |
Why?
|
Patient Satisfaction | 1 | 2005 | 460 | 0.200 |
Why?
|
Breast Feeding | 2 | 2005 | 98 | 0.200 |
Why?
|
Intraoperative Complications | 3 | 1994 | 188 | 0.200 |
Why?
|
Translating | 1 | 2001 | 18 | 0.200 |
Why?
|
Health Maintenance Organizations | 1 | 2001 | 20 | 0.200 |
Why?
|
Crohn Disease | 2 | 2005 | 750 | 0.200 |
Why?
|
Communication Barriers | 1 | 2001 | 29 | 0.200 |
Why?
|
Models, Psychological | 3 | 2011 | 158 | 0.190 |
Why?
|
Emotions | 1 | 2004 | 349 | 0.190 |
Why?
|
Intervertebral Disc | 3 | 1989 | 16 | 0.190 |
Why?
|
Age Factors | 9 | 2016 | 1863 | 0.180 |
Why?
|
Double-Blind Method | 15 | 2012 | 1716 | 0.180 |
Why?
|
Acute Kidney Injury | 2 | 1994 | 308 | 0.170 |
Why?
|
Surveys and Questionnaires | 5 | 2015 | 2595 | 0.170 |
Why?
|
Decision Making | 1 | 2005 | 661 | 0.170 |
Why?
|
Anesthesia, Intravenous | 6 | 1993 | 35 | 0.170 |
Why?
|
Propofol | 6 | 1993 | 91 | 0.160 |
Why?
|
Brain | 4 | 2001 | 2268 | 0.160 |
Why?
|
Ambulances | 1 | 2018 | 15 | 0.160 |
Why?
|
Patient Acceptance of Health Care | 1 | 2001 | 253 | 0.160 |
Why?
|
Pain, Postoperative | 2 | 1997 | 248 | 0.150 |
Why?
|
Infant Behavior | 1 | 1997 | 5 | 0.150 |
Why?
|
Analgesia, Patient-Controlled | 1 | 1997 | 16 | 0.150 |
Why?
|
Analgesia, Obstetrical | 1 | 1997 | 21 | 0.150 |
Why?
|
Analgesia, Epidural | 1 | 1997 | 38 | 0.150 |
Why?
|
Prostatic Neoplasms | 7 | 1997 | 1764 | 0.150 |
Why?
|
Sex Factors | 6 | 2014 | 1063 | 0.140 |
Why?
|
Chymopapain | 3 | 1985 | 6 | 0.140 |
Why?
|
Ethanol | 3 | 1993 | 250 | 0.130 |
Why?
|
Hospital Mortality | 1 | 2018 | 381 | 0.130 |
Why?
|
Population Surveillance | 1 | 2016 | 217 | 0.130 |
Why?
|
Wounds and Injuries | 1 | 2018 | 251 | 0.130 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 1995 | 186 | 0.130 |
Why?
|
Ambulatory Care | 1 | 2016 | 186 | 0.130 |
Why?
|
Antibiotic Prophylaxis | 1 | 2016 | 77 | 0.130 |
Why?
|
Follow-Up Studies | 8 | 2010 | 3657 | 0.130 |
Why?
|
Anesthesia, Spinal | 1 | 1994 | 15 | 0.120 |
Why?
|
Spinal Puncture | 1 | 1994 | 37 | 0.120 |
Why?
|
Postoperative Complications | 4 | 1994 | 2285 | 0.120 |
Why?
|
Intervertebral Disc Displacement | 2 | 1985 | 22 | 0.120 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 777 | 0.120 |
Why?
|
Headache | 1 | 1994 | 72 | 0.120 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2014 | 52 | 0.120 |
Why?
|
Hospitals | 1 | 2016 | 298 | 0.120 |
Why?
|
Surgical Wound Infection | 1 | 2016 | 199 | 0.120 |
Why?
|
Decompressive Craniectomy | 1 | 2014 | 18 | 0.120 |
Why?
|
Dura Mater | 1 | 2014 | 44 | 0.110 |
Why?
|
Endopeptidases | 2 | 1985 | 117 | 0.110 |
Why?
|
Thiopental | 1 | 1993 | 15 | 0.110 |
Why?
|
Influenza, Human | 1 | 2016 | 333 | 0.110 |
Why?
|
Prospective Studies | 11 | 2012 | 4271 | 0.110 |
Why?
|
Interviews as Topic | 4 | 2014 | 333 | 0.110 |
Why?
|
Brain Edema | 1 | 2014 | 57 | 0.110 |
Why?
|
Cerebral Infarction | 1 | 2014 | 72 | 0.110 |
Why?
|
Prevalence | 3 | 2015 | 1252 | 0.110 |
Why?
|
Adolescent | 17 | 2018 | 9161 | 0.110 |
Why?
|
Survival Analysis | 6 | 2005 | 1542 | 0.110 |
Why?
|
Hostility | 3 | 2010 | 24 | 0.110 |
Why?
|
Electronic Health Records | 1 | 2016 | 341 | 0.110 |
Why?
|
Cause of Death | 2 | 2013 | 270 | 0.110 |
Why?
|
Excitatory Amino Acid Antagonists | 3 | 2012 | 79 | 0.110 |
Why?
|
Hospitals, Community | 2 | 1989 | 32 | 0.110 |
Why?
|
Skin Temperature | 1 | 1992 | 15 | 0.110 |
Why?
|
Sex Characteristics | 3 | 2010 | 321 | 0.110 |
Why?
|
Aggression | 1 | 1996 | 323 | 0.100 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 510 | 0.100 |
Why?
|
Body Temperature | 1 | 1992 | 125 | 0.100 |
Why?
|
Sensation | 1 | 1992 | 47 | 0.100 |
Why?
|
Cold Temperature | 1 | 1992 | 160 | 0.100 |
Why?
|
Long QT Syndrome | 1 | 2012 | 36 | 0.100 |
Why?
|
Body Surface Area | 1 | 1992 | 36 | 0.100 |
Why?
|
Obesity, Morbid | 1 | 1994 | 230 | 0.100 |
Why?
|
National Health Programs | 2 | 2001 | 19 | 0.100 |
Why?
|
Socioeconomic Factors | 4 | 2010 | 579 | 0.100 |
Why?
|
Tremor | 1 | 1991 | 22 | 0.100 |
Why?
|
Body Temperature Regulation | 1 | 1991 | 56 | 0.100 |
Why?
|
Lidocaine | 1 | 1991 | 64 | 0.100 |
Why?
|
Patient Selection | 3 | 2014 | 689 | 0.100 |
Why?
|
Affective Symptoms | 1 | 2010 | 50 | 0.090 |
Why?
|
Proportional Hazards Models | 5 | 2005 | 859 | 0.090 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2012 | 136 | 0.090 |
Why?
|
Product Surveillance, Postmarketing | 7 | 1993 | 38 | 0.090 |
Why?
|
Life Change Events | 1 | 2010 | 48 | 0.090 |
Why?
|
Chicago | 5 | 2018 | 1411 | 0.090 |
Why?
|
Regression Analysis | 3 | 2004 | 594 | 0.090 |
Why?
|
Models, Cardiovascular | 1 | 2010 | 104 | 0.090 |
Why?
|
Stress, Psychological | 3 | 2010 | 321 | 0.090 |
Why?
|
Hip Fractures | 2 | 2001 | 46 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2010 | 1945 | 0.090 |
Why?
|
Information Systems | 1 | 1989 | 29 | 0.090 |
Why?
|
Blood Pressure | 2 | 2010 | 893 | 0.090 |
Why?
|
Drug Administration Schedule | 5 | 2005 | 902 | 0.090 |
Why?
|
Anesthesia Recovery Period | 3 | 1993 | 56 | 0.080 |
Why?
|
Treatment Outcome | 8 | 2016 | 8182 | 0.080 |
Why?
|
Kidney Calculi | 2 | 2003 | 340 | 0.080 |
Why?
|
Activities of Daily Living | 1 | 2010 | 207 | 0.080 |
Why?
|
Cholesterol, VLDL | 1 | 2008 | 14 | 0.080 |
Why?
|
Receptors, LDL | 1 | 2008 | 54 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 1057 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2005 | 2746 | 0.080 |
Why?
|
Drug Combinations | 4 | 2012 | 203 | 0.080 |
Why?
|
Heart Diseases | 2 | 2005 | 297 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2012 | 352 | 0.080 |
Why?
|
Health Status Indicators | 2 | 2003 | 104 | 0.080 |
Why?
|
Craniocerebral Trauma | 1 | 1988 | 54 | 0.080 |
Why?
|
Attitude to Health | 2 | 2009 | 221 | 0.080 |
Why?
|
Aortic Diseases | 1 | 2008 | 99 | 0.080 |
Why?
|
Heart Rate | 1 | 2010 | 492 | 0.080 |
Why?
|
Cervical Vertebrae | 1 | 1988 | 81 | 0.080 |
Why?
|
Pregnancy | 5 | 1997 | 2997 | 0.070 |
Why?
|
Pain | 2 | 2006 | 401 | 0.070 |
Why?
|
Preoperative Care | 4 | 1994 | 398 | 0.070 |
Why?
|
Anaphylaxis | 3 | 1998 | 33 | 0.070 |
Why?
|
Risk Assessment | 5 | 2013 | 2286 | 0.070 |
Why?
|
Motor Activity | 1 | 2009 | 328 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2016 | 8897 | 0.070 |
Why?
|
Mesalamine | 2 | 2004 | 88 | 0.070 |
Why?
|
Chromatography, Liquid | 1 | 2006 | 106 | 0.070 |
Why?
|
Evaluation Studies as Topic | 2 | 2004 | 270 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2006 | 193 | 0.070 |
Why?
|
Desipramine | 2 | 1995 | 9 | 0.070 |
Why?
|
Anesthesiology | 3 | 2000 | 160 | 0.070 |
Why?
|
Emigration and Immigration | 1 | 2005 | 49 | 0.060 |
Why?
|
Mexican Americans | 1 | 2005 | 66 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2008 | 255 | 0.060 |
Why?
|
Clinical Trials as Topic | 4 | 1999 | 1142 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2004 | 242 | 0.060 |
Why?
|
Affect | 2 | 2006 | 387 | 0.060 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2005 | 24 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2005 | 902 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2005 | 360 | 0.060 |
Why?
|
Receptors, Dopamine D2 | 1 | 2005 | 57 | 0.060 |
Why?
|
Overweight | 1 | 2005 | 118 | 0.060 |
Why?
|
Psychomotor Performance | 3 | 1993 | 497 | 0.060 |
Why?
|
Endpoint Determination | 1 | 2004 | 60 | 0.060 |
Why?
|
Mercaptopurine | 1 | 2004 | 53 | 0.060 |
Why?
|
Life Expectancy | 2 | 2003 | 87 | 0.060 |
Why?
|
Muscle Weakness | 1 | 2004 | 60 | 0.060 |
Why?
|
Reference Values | 1 | 2005 | 665 | 0.060 |
Why?
|
Coronary Disease | 1 | 2005 | 261 | 0.060 |
Why?
|
Electromyography | 1 | 2004 | 193 | 0.060 |
Why?
|
Surgical Procedures, Operative | 2 | 1999 | 205 | 0.060 |
Why?
|
Sciatica | 1 | 1983 | 4 | 0.060 |
Why?
|
Cohort Studies | 4 | 2012 | 2837 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2005 | 278 | 0.060 |
Why?
|
General Surgery | 2 | 1999 | 235 | 0.060 |
Why?
|
Prognosis | 3 | 2005 | 3750 | 0.050 |
Why?
|
Prostatectomy | 2 | 1997 | 476 | 0.050 |
Why?
|
Drug Interactions | 4 | 2004 | 248 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2005 | 837 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 1983 | 111 | 0.050 |
Why?
|
Anesthesia, General | 2 | 2001 | 116 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2005 | 995 | 0.050 |
Why?
|
Reye Syndrome | 1 | 1982 | 22 | 0.050 |
Why?
|
Lactates | 1 | 1982 | 37 | 0.050 |
Why?
|
Behavior, Animal | 1 | 2005 | 376 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2012 | 1709 | 0.050 |
Why?
|
Cartilage, Articular | 1 | 2002 | 69 | 0.050 |
Why?
|
Herpes Labialis | 1 | 2001 | 9 | 0.050 |
Why?
|
New England | 1 | 2001 | 10 | 0.050 |
Why?
|
Fatty Alcohols | 1 | 2001 | 10 | 0.050 |
Why?
|
Medical History Taking | 2 | 1992 | 81 | 0.050 |
Why?
|
Portugal | 1 | 2001 | 26 | 0.050 |
Why?
|
Midazolam | 2 | 1991 | 48 | 0.050 |
Why?
|
Research Design | 1 | 2005 | 594 | 0.050 |
Why?
|
Heart | 2 | 1995 | 572 | 0.050 |
Why?
|
Anesthesia | 2 | 1993 | 169 | 0.050 |
Why?
|
Nephrectomy | 1 | 2003 | 294 | 0.050 |
Why?
|
Pain Measurement | 3 | 2006 | 329 | 0.050 |
Why?
|
Nutrition Surveys | 1 | 2001 | 111 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2003 | 319 | 0.050 |
Why?
|
Spinal Fractures | 1 | 2001 | 76 | 0.050 |
Why?
|
Electroencephalography | 3 | 2001 | 741 | 0.050 |
Why?
|
School Health Services | 1 | 1980 | 15 | 0.050 |
Why?
|
Awareness | 1 | 2001 | 89 | 0.050 |
Why?
|
Proctitis | 1 | 2000 | 12 | 0.050 |
Why?
|
Critical Care | 2 | 2014 | 379 | 0.050 |
Why?
|
Bupivacaine | 2 | 2002 | 45 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2006 | 1843 | 0.040 |
Why?
|
Homicide | 2 | 1977 | 43 | 0.040 |
Why?
|
Echocardiography | 3 | 1994 | 932 | 0.040 |
Why?
|
Random Allocation | 4 | 1995 | 329 | 0.040 |
Why?
|
Infant, Newborn | 2 | 1997 | 2446 | 0.040 |
Why?
|
Geographic Mapping | 1 | 2018 | 12 | 0.040 |
Why?
|
Writing | 1 | 1999 | 29 | 0.040 |
Why?
|
Probability | 4 | 1992 | 356 | 0.040 |
Why?
|
Kidney | 1 | 2003 | 1145 | 0.040 |
Why?
|
Quality of Life | 2 | 2006 | 1651 | 0.040 |
Why?
|
Vancomycin | 1 | 1998 | 73 | 0.040 |
Why?
|
Mastectomy | 1 | 2000 | 245 | 0.040 |
Why?
|
Frontal Lobe | 2 | 1996 | 131 | 0.040 |
Why?
|
Injury Severity Score | 1 | 2018 | 129 | 0.040 |
Why?
|
Child | 5 | 2016 | 7091 | 0.040 |
Why?
|
Depression, Chemical | 1 | 1997 | 28 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 1998 | 146 | 0.040 |
Why?
|
Meperidine | 1 | 1997 | 13 | 0.040 |
Why?
|
Trauma Centers | 1 | 2018 | 132 | 0.040 |
Why?
|
Clinical Protocols | 2 | 2014 | 157 | 0.040 |
Why?
|
Milk, Human | 1 | 1997 | 44 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2001 | 515 | 0.040 |
Why?
|
Monitoring, Physiologic | 2 | 2014 | 266 | 0.040 |
Why?
|
Neurologic Examination | 1 | 1997 | 119 | 0.040 |
Why?
|
Injections, Intravenous | 3 | 1992 | 240 | 0.040 |
Why?
|
Survival Rate | 2 | 2003 | 1883 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2001 | 481 | 0.040 |
Why?
|
Rage | 1 | 1996 | 1 | 0.040 |
Why?
|
Ambulatory Surgical Procedures | 2 | 1995 | 75 | 0.040 |
Why?
|
Dangerous Behavior | 1 | 1996 | 4 | 0.040 |
Why?
|
Irritable Mood | 1 | 1996 | 10 | 0.040 |
Why?
|
Meta-Analysis as Topic | 2 | 1994 | 86 | 0.040 |
Why?
|
Glutamine | 1 | 1997 | 79 | 0.040 |
Why?
|
Residence Characteristics | 1 | 1998 | 196 | 0.040 |
Why?
|
Carbamazepine | 1 | 1996 | 9 | 0.030 |
Why?
|
Incidence | 3 | 1998 | 1592 | 0.030 |
Why?
|
Periodicals as Topic | 1 | 1999 | 169 | 0.030 |
Why?
|
Symptom Assessment | 1 | 2016 | 65 | 0.030 |
Why?
|
Basal Ganglia | 1 | 1996 | 45 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1997 | 114 | 0.030 |
Why?
|
Eye Diseases | 1 | 1996 | 58 | 0.030 |
Why?
|
Anesthetics | 1 | 1996 | 53 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2000 | 235 | 0.030 |
Why?
|
Graft Survival | 1 | 2000 | 918 | 0.030 |
Why?
|
Endothelins | 1 | 1995 | 26 | 0.030 |
Why?
|
Risk-Taking | 1 | 1977 | 155 | 0.030 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 1995 | 21 | 0.030 |
Why?
|
Functional Laterality | 1 | 1996 | 201 | 0.030 |
Why?
|
Young Adult | 2 | 2018 | 6220 | 0.030 |
Why?
|
Peptides, Cyclic | 1 | 1995 | 44 | 0.030 |
Why?
|
Cryosurgery | 1 | 1995 | 52 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 2 | 1992 | 76 | 0.030 |
Why?
|
Temporal Lobe | 1 | 1996 | 174 | 0.030 |
Why?
|
Seasons | 1 | 2016 | 233 | 0.030 |
Why?
|
Data Interpretation, Statistical | 2 | 2014 | 299 | 0.030 |
Why?
|
Child, Preschool | 2 | 2016 | 3678 | 0.030 |
Why?
|
Death, Sudden | 1 | 1995 | 40 | 0.030 |
Why?
|
Knee Injuries | 1 | 1995 | 54 | 0.030 |
Why?
|
Suicide | 1 | 1977 | 151 | 0.030 |
Why?
|
Radiography | 2 | 1988 | 807 | 0.030 |
Why?
|
Subarachnoid Hemorrhage | 1 | 1995 | 139 | 0.030 |
Why?
|
Arthroscopy | 1 | 1995 | 93 | 0.030 |
Why?
|
Violence | 1 | 1996 | 151 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 1994 | 145 | 0.030 |
Why?
|
Nasal Mucosa | 1 | 1994 | 191 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 1995 | 195 | 0.030 |
Why?
|
Pharmacoepidemiology | 1 | 1993 | 6 | 0.030 |
Why?
|
Wakefulness | 1 | 2014 | 134 | 0.030 |
Why?
|
Ischemic Attack, Transient | 1 | 1995 | 182 | 0.030 |
Why?
|
Nasal Polyps | 1 | 1994 | 60 | 0.030 |
Why?
|
Graft Rejection | 1 | 2000 | 1083 | 0.030 |
Why?
|
Gambling | 1 | 1977 | 156 | 0.030 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2014 | 38 | 0.030 |
Why?
|
Bradycardia | 1 | 1993 | 39 | 0.030 |
Why?
|
Anesthesia, Inhalation | 1 | 1993 | 36 | 0.030 |
Why?
|
Epilepsy | 1 | 1998 | 421 | 0.030 |
Why?
|
Coronary Artery Bypass | 2 | 1992 | 235 | 0.030 |
Why?
|
Sample Size | 1 | 2014 | 129 | 0.030 |
Why?
|
Intracranial Pressure | 1 | 2014 | 87 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 1994 | 149 | 0.030 |
Why?
|
Colitis, Ulcerative | 1 | 2000 | 725 | 0.030 |
Why?
|
Data Collection | 1 | 2014 | 374 | 0.030 |
Why?
|
Hypotension | 1 | 1993 | 70 | 0.030 |
Why?
|
Isoflurane | 1 | 1993 | 64 | 0.030 |
Why?
|
Sulfonamides | 1 | 1995 | 318 | 0.030 |
Why?
|
Hypersensitivity | 1 | 1994 | 158 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2000 | 853 | 0.030 |
Why?
|
Nitrous Oxide | 1 | 1993 | 107 | 0.030 |
Why?
|
Whole Blood Coagulation Time | 1 | 1992 | 7 | 0.030 |
Why?
|
Aprotinin | 1 | 1992 | 26 | 0.030 |
Why?
|
Pulmonary Gas Exchange | 1 | 1992 | 32 | 0.030 |
Why?
|
Arousal | 1 | 1993 | 170 | 0.030 |
Why?
|
Rhinitis | 1 | 1994 | 177 | 0.030 |
Why?
|
HIV Seropositivity | 1 | 1992 | 51 | 0.030 |
Why?
|
Electrocardiography | 2 | 2010 | 495 | 0.030 |
Why?
|
Mental Disorders | 2 | 1995 | 408 | 0.030 |
Why?
|
Body Constitution | 1 | 1992 | 26 | 0.030 |
Why?
|
Albumins | 1 | 1992 | 130 | 0.030 |
Why?
|
Prefrontal Cortex | 1 | 1993 | 133 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 1992 | 48 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 1997 | 802 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 1992 | 70 | 0.030 |
Why?
|
Registries | 1 | 1996 | 760 | 0.030 |
Why?
|
Oxygen | 3 | 2010 | 743 | 0.030 |
Why?
|
Thrombelastography | 1 | 1992 | 47 | 0.020 |
Why?
|
Calibration | 1 | 1992 | 102 | 0.020 |
Why?
|
Case-Control Studies | 1 | 1996 | 1851 | 0.020 |
Why?
|
Injections, Epidural | 1 | 1991 | 6 | 0.020 |
Why?
|
Placebos | 1 | 2012 | 214 | 0.020 |
Why?
|
Body Height | 1 | 1992 | 100 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 1992 | 115 | 0.020 |
Why?
|
Fentanyl | 1 | 1991 | 67 | 0.020 |
Why?
|
Cortical Spreading Depression | 1 | 1991 | 21 | 0.020 |
Why?
|
Diagnostic Self Evaluation | 1 | 2011 | 12 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1991 | 59 | 0.020 |
Why?
|
Creatinine | 2 | 2003 | 295 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 1992 | 252 | 0.020 |
Why?
|
Pilot Projects | 1 | 2014 | 867 | 0.020 |
Why?
|
Postpartum Period | 1 | 1992 | 143 | 0.020 |
Why?
|
Remission Induction | 2 | 2004 | 735 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 2010 | 707 | 0.020 |
Why?
|
Pulmonary Artery | 1 | 1992 | 317 | 0.020 |
Why?
|
Body Weight | 1 | 1992 | 455 | 0.020 |
Why?
|
Weight Loss | 1 | 1992 | 226 | 0.020 |
Why?
|
Learning | 1 | 1993 | 283 | 0.020 |
Why?
|
Infant | 1 | 2016 | 3118 | 0.020 |
Why?
|
Lumbosacral Region | 1 | 1989 | 27 | 0.020 |
Why?
|
Death | 1 | 2010 | 84 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 865 | 0.020 |
Why?
|
Podophyllotoxin | 1 | 1989 | 10 | 0.020 |
Why?
|
Condylomata Acuminata | 1 | 1989 | 15 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1992 | 333 | 0.020 |
Why?
|
Penile Diseases | 1 | 1989 | 8 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2011 | 491 | 0.020 |
Why?
|
Self Administration | 1 | 1989 | 72 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1995 | 1352 | 0.020 |
Why?
|
Somatomedins | 1 | 1989 | 28 | 0.020 |
Why?
|
Insulin-Like Growth Factor II | 1 | 1989 | 33 | 0.020 |
Why?
|
Social Identification | 1 | 2009 | 26 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2008 | 15 | 0.020 |
Why?
|
Attention | 1 | 1993 | 390 | 0.020 |
Why?
|
Receptor, Insulin | 1 | 1989 | 54 | 0.020 |
Why?
|
Personality Inventory | 1 | 2009 | 109 | 0.020 |
Why?
|
Immunocompetence | 1 | 2008 | 27 | 0.020 |
Why?
|
Demography | 1 | 1989 | 181 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1989 | 147 | 0.020 |
Why?
|
Pregnancy in Diabetics | 1 | 1989 | 38 | 0.020 |
Why?
|
Injections | 2 | 1992 | 115 | 0.020 |
Why?
|
Acute Disease | 2 | 2001 | 838 | 0.020 |
Why?
|
Cognition | 1 | 1993 | 579 | 0.020 |
Why?
|
Health Behavior | 1 | 2010 | 183 | 0.020 |
Why?
|
Fractures, Closed | 1 | 1988 | 9 | 0.020 |
Why?
|
Algorithms | 1 | 2016 | 1868 | 0.020 |
Why?
|
Postoperative Period | 2 | 2004 | 305 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 1992 | 602 | 0.020 |
Why?
|
Rats | 3 | 2005 | 4041 | 0.020 |
Why?
|
Joint Dislocations | 1 | 1988 | 27 | 0.020 |
Why?
|
Triglycerides | 1 | 2008 | 232 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2008 | 166 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2008 | 223 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 1988 | 94 | 0.020 |
Why?
|
Practice Patterns, Physicians' | 1 | 1992 | 597 | 0.020 |
Why?
|
Contrast Media | 1 | 1992 | 1088 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 1992 | 473 | 0.020 |
Why?
|
Students, Medical | 1 | 1992 | 418 | 0.020 |
Why?
|
Rorschach Test | 2 | 1977 | 3 | 0.020 |
Why?
|
Administration, Topical | 2 | 2001 | 96 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2000 | 2980 | 0.020 |
Why?
|
Animals | 6 | 2008 | 27235 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2000 | 1213 | 0.020 |
Why?
|
Social Behavior | 1 | 2008 | 297 | 0.020 |
Why?
|
Iothalamate Meglumine | 1 | 1985 | 5 | 0.020 |
Why?
|
Spasm | 1 | 1985 | 17 | 0.020 |
Why?
|
Apomorphine | 1 | 2005 | 10 | 0.020 |
Why?
|
Dopamine D2 Receptor Antagonists | 1 | 2005 | 7 | 0.020 |
Why?
|
Serotonin Receptor Agonists | 1 | 2005 | 15 | 0.020 |
Why?
|
Amphetamines | 1 | 2005 | 18 | 0.020 |
Why?
|
Haloperidol | 1 | 2005 | 30 | 0.020 |
Why?
|
Dopamine Agonists | 1 | 2005 | 27 | 0.020 |
Why?
|
Chronic Disease | 1 | 2008 | 948 | 0.020 |
Why?
|
Dopamine Antagonists | 1 | 2005 | 35 | 0.020 |
Why?
|
Serotonin Antagonists | 1 | 2005 | 35 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2005 | 101 | 0.020 |
Why?
|
Cytochrome P-450 CYP2D6 Inhibitors | 1 | 2004 | 5 | 0.020 |
Why?
|
Fluorobenzenes | 1 | 2005 | 33 | 0.020 |
Why?
|
Indans | 1 | 2005 | 35 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2004 | 120 | 0.020 |
Why?
|
Discrimination Learning | 1 | 2005 | 63 | 0.020 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2005 | 44 | 0.020 |
Why?
|
Stroke | 1 | 2014 | 979 | 0.020 |
Why?
|
Quinolines | 1 | 2005 | 91 | 0.020 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2004 | 52 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2004 | 87 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2004 | 154 | 0.010 |
Why?
|
Confidence Intervals | 2 | 1995 | 226 | 0.010 |
Why?
|
Amphetamine | 1 | 2005 | 101 | 0.010 |
Why?
|
Prostate-Specific Antigen | 2 | 1997 | 358 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2004 | 163 | 0.010 |
Why?
|
Piperidines | 1 | 2005 | 163 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 1987 | 0.010 |
Why?
|
Cues | 1 | 2005 | 177 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1989 | 562 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1983 | 138 | 0.010 |
Why?
|
HIV Infections | 1 | 1992 | 829 | 0.010 |
Why?
|
Hallucinogens | 1 | 2005 | 77 | 0.010 |
Why?
|
Recurrence | 2 | 2001 | 1168 | 0.010 |
Why?
|
Psychotic Disorders | 1 | 2005 | 192 | 0.010 |
Why?
|
Risk | 2 | 1995 | 660 | 0.010 |
Why?
|
Digestive System Surgical Procedures | 1 | 2004 | 124 | 0.010 |
Why?
|
Sulfur Oxides | 1 | 2002 | 4 | 0.010 |
Why?
|
Knee | 1 | 2002 | 17 | 0.010 |
Why?
|
Sodium Chloride | 1 | 2002 | 87 | 0.010 |
Why?
|
Pyruvates | 1 | 1982 | 11 | 0.010 |
Why?
|
Pyruvate Carboxylase | 1 | 1982 | 6 | 0.010 |
Why?
|
Pyruvate Dehydrogenase Complex | 1 | 1982 | 13 | 0.010 |
Why?
|
Ammonia | 1 | 1982 | 38 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2005 | 1237 | 0.010 |
Why?
|
Acidosis | 1 | 1982 | 55 | 0.010 |
Why?
|
Femur Neck | 1 | 2001 | 41 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 2002 | 76 | 0.010 |
Why?
|
Ointments | 1 | 2001 | 12 | 0.010 |
Why?
|
Coma | 1 | 1982 | 45 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 3195 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 646 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 2347 | 0.010 |
Why?
|
Cardiopulmonary Bypass | 2 | 1992 | 158 | 0.010 |
Why?
|
Denmark | 1 | 1980 | 17 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 2002 | 995 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2001 | 155 | 0.010 |
Why?
|
Bone Density | 1 | 2001 | 209 | 0.010 |
Why?
|
Fractures, Bone | 1 | 2001 | 123 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1989 | 1169 | 0.010 |
Why?
|
Histocompatibility | 1 | 2000 | 66 | 0.010 |
Why?
|
Treatment Failure | 1 | 2000 | 289 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2000 | 295 | 0.010 |
Why?
|
Chymases | 1 | 1998 | 11 | 0.010 |
Why?
|
Tryptases | 1 | 1998 | 12 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2000 | 471 | 0.010 |
Why?
|
Quality Control | 1 | 1999 | 116 | 0.010 |
Why?
|
Mass Screening | 2 | 1993 | 631 | 0.010 |
Why?
|
Histamine | 1 | 1998 | 126 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2000 | 219 | 0.010 |
Why?
|
Technetium Tc 99m Exametazime | 1 | 1998 | 5 | 0.010 |
Why?
|
Blood Glucose | 1 | 1982 | 841 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2000 | 358 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1998 | 222 | 0.010 |
Why?
|
Geography | 1 | 1998 | 228 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 2000 | 258 | 0.010 |
Why?
|
Diazooxonorleucine | 1 | 1997 | 5 | 0.010 |
Why?
|
Space Flight | 1 | 1977 | 7 | 0.010 |
Why?
|
Conjunctivitis | 1 | 1996 | 6 | 0.010 |
Why?
|
Oxidants | 1 | 1997 | 86 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 1998 | 193 | 0.010 |
Why?
|
Corneal Diseases | 1 | 1996 | 33 | 0.010 |
Why?
|
Hot Temperature | 1 | 1997 | 208 | 0.010 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 1995 | 18 | 0.010 |
Why?
|
Europe | 1 | 1996 | 314 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 1995 | 107 | 0.010 |
Why?
|
Cerebral Arteries | 1 | 1995 | 75 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1995 | 105 | 0.010 |
Why?
|
Vasodilation | 1 | 1995 | 94 | 0.010 |
Why?
|
Injections, Intra-Articular | 1 | 1995 | 27 | 0.010 |
Why?
|
Carotid Artery, Internal | 1 | 1995 | 70 | 0.010 |
Why?
|
Poisson Distribution | 1 | 1995 | 51 | 0.010 |
Why?
|
Radioallergosorbent Test | 1 | 1994 | 8 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 1995 | 198 | 0.010 |
Why?
|
Radionuclide Ventriculography | 1 | 1994 | 3 | 0.010 |
Why?
|
Thallium Radioisotopes | 1 | 1994 | 5 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 1995 | 197 | 0.010 |
Why?
|
Medicare | 1 | 1998 | 420 | 0.010 |
Why?
|
Drug Utilization | 1 | 1995 | 65 | 0.010 |
Why?
|
Mice | 1 | 2008 | 11707 | 0.010 |
Why?
|
Immunotherapy | 1 | 2000 | 661 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 1995 | 144 | 0.010 |
Why?
|
Bias | 1 | 1994 | 130 | 0.010 |
Why?
|
Biomarkers | 1 | 2000 | 1756 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1994 | 238 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1998 | 2019 | 0.010 |
Why?
|
San Francisco | 1 | 1992 | 23 | 0.010 |
Why?
|
Diatomaceous Earth | 1 | 1992 | 3 | 0.010 |
Why?
|
Kaolin | 1 | 1992 | 9 | 0.010 |
Why?
|
Medical Audit | 1 | 1992 | 39 | 0.010 |
Why?
|
Partial Thromboplastin Time | 1 | 1992 | 18 | 0.010 |
Why?
|
New York | 1 | 1992 | 70 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 1992 | 33 | 0.010 |
Why?
|
Narcolepsy | 1 | 1992 | 9 | 0.010 |
Why?
|
Viral Hepatitis Vaccines | 1 | 1992 | 5 | 0.010 |
Why?
|
Sleep, REM | 1 | 1992 | 51 | 0.010 |
Why?
|
Hepatitis B Vaccines | 1 | 1992 | 15 | 0.010 |
Why?
|
Cost Savings | 1 | 1992 | 69 | 0.010 |
Why?
|
Attitude to Computers | 1 | 1992 | 12 | 0.010 |
Why?
|
Preventive Medicine | 1 | 1992 | 17 | 0.010 |
Why?
|
Cell Line | 1 | 1997 | 2498 | 0.010 |
Why?
|
Microspheres | 1 | 1992 | 108 | 0.010 |
Why?
|
Particle Size | 1 | 1992 | 124 | 0.010 |
Why?
|
Hematocrit | 1 | 1992 | 68 | 0.010 |
Why?
|
Hospitals, University | 1 | 1992 | 195 | 0.010 |
Why?
|
False Negative Reactions | 1 | 1992 | 63 | 0.010 |
Why?
|
Medical Records | 1 | 1992 | 121 | 0.010 |
Why?
|
Blood Coagulation Tests | 1 | 1992 | 35 | 0.010 |
Why?
|
Serum Albumin | 1 | 1992 | 128 | 0.010 |
Why?
|
Health Services Research | 1 | 1992 | 137 | 0.010 |
Why?
|
Physical Examination | 1 | 1993 | 148 | 0.010 |
Why?
|
Hepatitis B | 1 | 1992 | 76 | 0.010 |
Why?
|
Heparin | 1 | 1992 | 184 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1991 | 87 | 0.010 |
Why?
|
Computers | 1 | 1991 | 112 | 0.010 |
Why?
|
Heart Valve Prosthesis | 1 | 1992 | 97 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 1997 | 1983 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1992 | 202 | 0.010 |
Why?
|
Dogs | 1 | 1992 | 704 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1991 | 312 | 0.010 |
Why?
|
Drainage | 1 | 1992 | 158 | 0.010 |
Why?
|
Sleep Wake Disorders | 1 | 1992 | 116 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1991 | 306 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1997 | 2009 | 0.010 |
Why?
|
Heart Atria | 1 | 1992 | 281 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 1991 | 202 | 0.010 |
Why?
|
Parietal Lobe | 1 | 1991 | 117 | 0.010 |
Why?
|
Language | 1 | 1991 | 154 | 0.010 |
Why?
|
DNA Probes | 1 | 1989 | 77 | 0.010 |
Why?
|
Monosaccharide Transport Proteins | 1 | 1989 | 73 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1989 | 156 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 1991 | 274 | 0.010 |
Why?
|
Schizophrenia | 1 | 1992 | 477 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1992 | 1588 | 0.000 |
Why?
|
Heart Ventricles | 1 | 1992 | 779 | 0.000 |
Why?
|
Gene Frequency | 1 | 1989 | 684 | 0.000 |
Why?
|
Anesthesia, Local | 1 | 1985 | 27 | 0.000 |
Why?
|
Histamine H1 Antagonists | 1 | 1985 | 40 | 0.000 |
Why?
|
Chromosome Mapping | 1 | 1989 | 1077 | 0.000 |
Why?
|
Sympathetic Nervous System | 1 | 1985 | 94 | 0.000 |
Why?
|
Genotype | 1 | 1989 | 1867 | 0.000 |
Why?
|
Models, Genetic | 1 | 1989 | 942 | 0.000 |
Why?
|
Prisoners | 1 | 1975 | 44 | 0.000 |
Why?
|